Inventor · disambiguated record
Tanja Denise De Gruijl
Also filed as: DE GRUIJL TANJA DENISE
8 granted patents·3 pending applications·17 citations·filing 2008–2024
82Inventor score
Files withLAVA THERAPEUTICS N V6LAVA THERAPEUTICS B V2ORCA THERAPEUTICS B V1STICHTING VUMC1VAN WETERING SANDRA1
Top patents by PatentIndex Score
11 records- 0193US11384145B2Immunoglobulins binding human Vγ9Vδ2 T cell receptorsLAVA THERAPEUTICS N V·Filed 2021·Granted Jul 12, 2022·3 cites·21 claims
- 0285US10501540B2Immunoglobulins binding human Vγ9 Vδ2 T cell receptorsSTICHTING VUMC·Filed 2015·Granted Dec 10, 2019·6 cites·16 claims
- 0383US11591394B2Single domain antibodies targeting CD1dLAVA THERAPEUTICS N V·Filed 2019·Granted Feb 28, 2023·2 cites·8 claims
- 0481US2024425592A1Single domain antibodies targeting cd1dLAVA THERAPEUTICS N V·Filed 2024·Application pending·0 cites
- 0580US10501541B2Single domain antibodies targeting CD1dLAVA THERAPEUTICS B V·Filed 2016·Granted Dec 10, 2019·5 cites·18 claims
- 0678US12110328B2Single domain antibodies targeting CD1dLAVA THERAPEUTICS N V·Filed 2023·Granted Oct 8, 2024·0 cites·15 claims
- 0776US2023212290A1Immunoglobulins binding human vgamma9vdelta2 t cell receptorsLAVA THERAPEUTICS N V·Filed 2022·Application pending·0 cites
- 0860US8470789B2Method for inducing and accelerating cellsVAN WETERING SANDRA·Filed 2008·Granted Jun 25, 2013·1 cites·14 claims
- 0950US12077586B2Bispecific antibodies for use in the treatment of hematological malignanciesLAVA THERAPEUTICS N V·Filed 2019·Granted Sep 3, 2024·0 cites·13 claims
- 1041US2022135694A1Novel cd40-binding antibodiesLAVA THERAPEUTICS B V·Filed 2020·Application pending·0 cites
- 1140US12233096B2Recombinant replication competent viruses comprising a coding region for glycogen synthase kinase-3 (GSK3) and methods of killing aberrant cellsORCA THERAPEUTICS B V·Filed 2019·Granted Feb 25, 2025·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Tanja Denise De Gruijl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →